Skip to content

Blood transfusions at home.

Blood transfusions at home; effects and costs compared to care as usual.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20522
Enrollment
80
Registered
2008-12-18
Start date
2003-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who require repeated transfusions of red blood cells or platelet, being mainly patients with anemia, thrombocytopenia for example after chemotherapy

Interventions

The intervention means that patients receive their blood transfusions at home. The transfusion is given by a nurse specialist according a previously set protocol. Controls receive care as usual (blood

Sponsors

Maastricht University Medical Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients in which transfusion is indicated; 2. poor health status in which transfusion at home is considered.

Exclusion criteria

Exclusion criteria: 1. Earlier transfusion reaction; 2. insufficient knowledge of Dutch language to fill in questionnaires; 3. poor health status in such a way that care as usual is not possible anymore; 4. refusal of the patient.

Design outcomes

Primary

MeasureTime frame
Quality of Life of participants costs of all participants from a societal perspective.

Secondary

MeasureTime frame
The number of adverse effects in both groups and the perceived Quality of Care.

Contacts

Public ContactRon A.G. Winkens

University Hospital Maastricht, Integrated care unit (Bze-7), P.O. Box 5800

ron.winkens@hag.unimaas.nl+31 (0)43 3877389

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)